Royal Biotek Enhances Everglade Line with New Products

Melbourne, FL – April 9, 2024 – Branded Legacy, Inc. (OTC.PK: BLEG),

a leading subsidiary of Branded Legacy, Inc. (Symbol: $BLEG), is proud to announce the expansion of its Everglade line, a distinguished collection of cannabis products, crafted exclusively for Surge Distribution Co. This expansion not only builds on the initial success of the Everglade gummies but also marks a significant stride in Royal Biotek’s commitment to delivering tailored cannabis solutions that meet the specific needs of Surge Distribution’s diverse clientele.

David Oswald, CEO of Royal Biotek, expressed enthusiasm about the launch: “We are thrilled to expand the Everglade line for Surge Distribution with the introduction of THCA Flower, featuring the iconic imagery and branding that have contributed to the success of this line. This addition is a testament to our ongoing commitment to customer satisfaction and reinforces our position as a trusted leader in premium cannabis offerings.”

Under this enhanced partnership, Royal Biotek will provide Surge Distribution with 4,000 packages of THCA Flower twice each quarter, generating a consistent revenue stream with each order valued at approximately $40,000. This development is expected to significantly contribute to Branded Legacy’s revenue growth in the early stages of the second quarter.

The expansion reflects Royal Biotek’s unwavering commitment to excellence, quality, and integrity within the cannabis industry. Every product within the Surge Everglade line is meticulously crafted using only the finest ingredients and cutting-edge manufacturing techniques to ensure unmatched potency, purity, and consistency.

“The addition of new products to the Everglade line is a pivotal moment for Royal Biotek, reinforcing our leadership in the fast-evolving cannabis and white label markets,” Oswald added. “Our dedication to innovation, customer satisfaction, and regulatory compliance continues to set the standards of excellence in the industry.”

In addition to expanding the Everglade line, Royal Biotek is excited to announce an upcoming collaboration with a well-known celebrity tattoo artist. This partnership aims to create a new, all-natural tattoo aftercare product. This move is also expected to significantly increase media exposure. Further details will be shared upon finalizing the contracts.

Branded Legacy also announced the signing of three white label agreements with Surge Distribution Company and Kava & Hobbs just last quarter. These new deals, increased revenue from quarter one by over $100,000.

About Royal Biotek

Royal Biotek, a subsidiary of Branded Legacy, Inc., is at the forefront of developing innovative cannabis solutions. With a focus on quality and customer-centric products, Royal Biotek continues to lead the market in creating unique cannabis experiences for its diverse customer base.

For more information about Royal Biotek and to explore their white label capabilities please visit: Royal Biotek White Label Program

 

Investor Relations & Media Contact:

Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com

Download this Press Release

 

Safe Harbor Statement on Forward-Looking Language: This release includes forward-looking statements, which are based on certain assumptions and reflect management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “intends,” “goal,” “objective,” “seek,” “attempt,” or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.